Phillip Stricker

Has grant

Conjoint Professor

University of New South Wales

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Phillip Stricker is a Conjoint Professor at the University of New South Wales in Australia. His research primarily focuses on prostate cancer, specifically in the areas of focal therapy and germline testing. Recent publications include comprehensive reviews and international studies evaluating treatment outcomes and prognostic factors related to prostate cancer. He is actively involved in refining therapeutic approaches to enhance patient care and clinical guidelines in the field.

Recent Grants

Grant: Close

PRIMARY Trial – Can combined multiparametric MRI and PSMA PET imaging replace prostate biopsy in the primary diagnosis of prostate cancer?

Open Date: 2019-01-01

Close Date: 2021-01-01

Grant: Close

DETECT trial: Radioguided surgery with technetium99m-labelled PSMA to aid intra-operative lymph node metastases detection for patients undergoing robot-assisted radical prostatectomy and extended-pelvic lymph node dissection for prostate cancer

Open Date: 2017-01-01

Close Date: 2018-01-01

Grant: Close

Australian Prostate Cancer Research Centres

Open Date: 2017-01-01

Close Date: 2018-01-01

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

William Gondoputro

Conjoint Associate Lecturer

University of New South Wales Medicine & Health

AUSTRALIA

View details

Ghamdan Al-Eryani

University of New South Wales

AUSTRALIA

View details

Daniel Moon

AUSTRALIA

View details

Mark Frydenberg

MONASH UNIVERSITY

AUSTRALIA

View details

Damien Bolton

AUSTRALIA

View details

Petr Macek

Institute Mutualiste Montsouris

FRANCE

View details

André Vis

M.D., Ph.D., Associate professor, Urologist

Amsterdam UMC

NETHERLANDS

View details

Kenneth Chen

Clinical Associate Professor

Syngenta Group

SINGAPORE

View details

Rafael Sanchez-Salas

McGill University

CANADA

View details

Daniel Moon

AUSTRALIA

View details

LARA RODRIGUEZ-SANCHEZ

Institute Mutualiste Montsouris

FRANCE

View details

Tahlia Scheinberg

Garvan Institute of Medical Research

AUSTRALIA

View details

Mark Emberton

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Phillip Stricker

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Refining partial gland ablation for localised prostate cancer: the FALCON project

Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men

Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer

Salvage treatments after focal therapy for prostate cancer – a comprehensive review

A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer

Reply to ‘Re: Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy’

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer

Salvage irreversible electroporation for radio-recurrent prostate cancer

Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

How Does Age Affect Urinary Continence following Robot-Assisted Radical Prostatectomy? A Prospective Multi-Institutional Study Using Independently Collected, Validated Questionnaires

Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer

High prostate‐specific membrane antigen ( <scp>PSMA) positron emission tomography (PET)</scp> maximum standardized uptake value in men <scp>with PI‐RADS</scp> score 4 or 5 confers a high probability of significant prostate cancer

Selection of patients for nerve sparing surgery in robot‐assisted radical prostatectomy

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase

Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

Collaborators (13)

William Gondoputro

Ghamdan Al-Eryani

Daniel Moon

Mark Frydenberg

Damien Bolton

Petr Macek

André Vis

Kenneth Chen

Rafael Sanchez-Salas

Daniel Moon

LARA RODRIGUEZ-SANCHEZ

Tahlia Scheinberg

Mark Emberton

Make your next move.